About PharmaDerm
PharmaDerm is a specialty pharmaceutical company dedicated to developing and commercializing prescription products to treat diseases and conditions of the skin—the largest organ of the human body. Our goal is to pursue development of products that will help improve the lives of patients with skin disease.
Our growing portfolio of products provide effective prescription therapies for the treatment of a variety of skin diseases including acne, actinic keratosis (AK), eczema, external genital warts, fungal disease, psoriasis and rosacea.
PharmaDerm, combined with our sister generic division, Fougera, is the number one manufacturer of topical pharmaceutical products in the United States. Over the last 8 years, we have developed over 60 FDA-approved topical therapies in the United States—more than any other company in that time frame.
PharmaDerm is uniquely positioned as a fully vertically-integrated specialty pharmaceutical company dedicated to skin disease with in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, sales and marketing.
Important Product Safety Information
OXISTAT® is approved for topical use in these skin infections:
- OXISTAT® CREAM and OXISTAT® LOTION—for athlete's foot, jock itch and ringworm due to Trichophyton rubrum, Trichophyton mentagrophytes, or Epidermophyton floccosum.
- OXISTAT® CREAM—for tinea (pityriasis) versicolor due to Malassezia furfur.
- OXISTAT® CREAM—for ringworm, jock itch and tinea (pityriasis) versicolor in children. Please note: these conditions are rare in children under age 12.
The most common side effects reported with OXISTAT® were itching and burning.
OXISTAT® CREAM and OXISTAT® LOTION are not for ophthalmic or intravaginal use.
For more information, consult your healthcare provider.
Please see the link to the Full Prescribing Information below.
OXISTAT® (oxiconazole nitrate) Cream & Lotion Full Prescribing Information
